Göran Walldius

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations

Medicine, Cardiology, Clinical Cardiology +11

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Göran Walldius, Ingmar Jungner, Ingar Holme et al. · The Lancet · 2001 · 1.2K citations

Medicine, Cardiology, Internal Medicine +17

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Philip J. Barter, Christie M. Ballantyne, Rafael Carmena et al. · Journal of Internal Medicine · 2006 · 471 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

AD Sniderman, C.D. Furberg, Anthony Keech et al. · The Lancet · 2003 · 461 citations

Medicine, Biochemistry, Cardiology +14

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

Ingar Holme, Are H. Aastveit, Niklas Hammar et al. · Journal of Internal Medicine · 2009 · 316 citations

Medicine, Cardiology, Geriatric Medicine +15